ImmuPharma PLC (LON:IMM)


Drug discovery and development company, ImmuPharma plc (LON: IMM) is into the business of drug development, primarily based on peptide therapeutics, which helps in the treatment of serious health disorders such as autoimmune diseases. The Company has several patents, platform technologies and many drug candidates such as Lupuzor, which helps in treatment of life-threatening auto-immune diseases. The research work of the company is mostly carried out in France.

Similar Companies